124 - Therapy for Carbapenem-Resistant Organisms in the Real World

Moderator(s)

• 

  Rebecca Kumar, MD (she/her/hers)

  Assistant Professor
  Georgetown University School of Medicine
  Washington , DC, United States
• 

  Jason Gallagher, PharmD

  Clinical Professor
  Temple University
  Philadelphia, PA, United States

Presentations:

• 10:30 AM – 10:42 AM US PT

  A comparative study on the effectiveness and safety between colistin-based and high-dose ampicillin/sulbactam-based combination therapy for nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii
  

  Presenting Author: Jaehoon T. Lee (he/him/his) – Hallym University Chuncheon Sacred Heart Hospital

  Co-Author: Imchang Lee, n/a – Hallym University Chuncheon Sacred Heart Hospital

  Co-Author: Ki-Byung Lee, n/a – Hallym University Chuncheon Sacred Heart Hospital

  Co-Author: Seung Soon Lee, MD – Hallym University Chuncheon Sacred Heart Hospital
• 10:42 AM – 10:54 AM US PT

  Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)
  

  Presenting Author: jason M. Pogue, PharmD – University of Michigan, College of Pharmacy

  Co-Author: Lilian M. Abbo, MD, MBA (she/her/hers) – University of Miami Miller School of Medicine, Jackson Health System

  Co-Author: Renee Ackley, PharmD, BCPS, BCIDP – Atrium Health

  Co-Author: Samuel L. Aitken, PharmD, MPH – Michigan Medicine

  Co-Author: Benjamin Albrecht, PharmD, BCIDP (he/him/his) – Emory University Hospital

  Co-Author: Ahmed Babiker, MBBS – Emory University

  Co-Author: Rachel Burgoon, Pharm.D. – Medical University of South Carolina

  Co-Author: Kimberly C. Claeys, PharmD, PhD (she/her/hers) – University of Maryland Baltimore

  Co-Author: Brooke Curry, PharmD – University of Illinois at Chicago

  Co-Author: Kate DeSear, PharmD, BCIDP, AAHIVP, FIDSA (she/her/hers) – UF Health Shands Hospital

  Co-Author: Jason C. Gallagher, PharmD – Temple University

  Co-Author: Esther Golnabi, PharmD – UT Southwestern

  Co-Author: Sarah B. Green, PharmD, BCIDP, AAHIVP – Emory University Hospital

  Co-Author: Alan E. Gross, PharmD – University of Illinois

  Co-Author: Emily L. Heil, PharmD, MS – University of Maryland School of Pharmacy

  Co-Author: Krutika M. Hornback, PharmD, BCIDP (she/her/hers) – MUSC Health

  Co-Author: Keith S. Kaye, MD, MPH – Rutgers Robert Wood Johnson Medical School

  Co-Author: Trieu-Vi Khuu, NA – University of North Carolina

  Co-Author: Megan Klatt, PharmD, BCIDP (she/her/hers) – The University of Kansas Health System

  Co-Author: Ellen G. Kline, MS – University of Pittsburgh

  Co-Author: Ryan C. Kubat, DO – University of Kansas

  Co-Author: Wesley D. Kufel, Pharm.D., BCPS, BCIDP – Binghamton University School of Pharmacy Sciences

  Co-Author: Alexander Lepak, MD, FIDSA – University of Wisconsin School of Medicine and Public Health

  Co-Author: Conan MacDougall, PharmD, MAS (he/him/his) – University of California San Francisco

  Co-Author: Anjali Majumdar, MD – Rutgers-Robert Wood Johnson Medical School

  Co-Author: Amy Mathers, MD, D(ABMM) (she/her/hers) – University of Virginia

  Co-Author: Erin K. McCreary, PharmD (she/her/hers) – University of Pittsburgh Medical Center

  Co-Author: William R. Miller, M.D. – Houston Methodist Research Institute

  Co-Author: Marguerite Monogue, PharmD – University of Texas Southwestern Medical Center

  Co-Author: W. Justin Moore, PharmD, MS, BCPS, BCIDP (he/him/his) – Northwestern Medicine

  Co-Author: Shannon Olson, BS Pharm,BCIDP – Sinai-Grace Hospital Detroit Medical Center

  Co-Author: Jessica Oxer, n/a – Weill Cornell Medicine

  Co-Author: Jeffrey C. Pearson, PharmD (he/him/his) – Brigham and Women's Hospital

  Co-Author: Christine Pham, PharmD, BCIDP – University of California, Los Angeles; David School of Medicine/University of California, Los Angeles

  Co-Author: Paulette Pinargote, MD – Lousiana State University Health Shreveport

  Co-Author: Christopher Polk, MD – Atrium Health

  Co-Author: Michael J. Satlin, MD – Weill Cornell Medicine

  Co-Author: Sarah W. Satola, PhD – Emory University School of Medicine, Division of Infectious Diseases

  Co-Author: Sunish Shah, PharmD – Antibiotic Management Program, UPMC Presbyterian Hospital, Pittsburgh, PA

  Co-Author: Pranita Tamma, MD, MHS – Johns Hopkins School of Medicine

  Co-Author: Truc Cecilia Tran, PharmD – Houston Methodist Research Institute

  Co-Author: David van Duin, MD, PhD – University of North Carolina at Chapel Hill

  Co-Author: Mollie VanNatta, PharmD, BCPS,BCIDP – Ochsner LSU Health Shreveport

  Co-Author: Ana Vega, PharmD – Jackson Memorial Hospital

  Co-Author: Venugopalan Veena, PharmD – University of Florida, College of Pharmacy

  Co-Author: Michael P. Veve, PharmD, MPH – Eugene Applebaum College of Pharmacy and Health Sciences

  Co-Author: Walaiporn Wangchinda, MD – University of Michigan College of Pharmacy

  Co-Author: Lucy S. Witt, MD, MPH – Emory University

  Co-Author: Janet Wu, PharmD – Cleveland Clinic

  Co-Author: Ryan K. Shields, PharmD, MS – University of Pittsburgh
• 10:54 AM – 11:06 AM US PT

  Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)
  

  Presenting Author: Michael P. Veve, PharmD, MPH – Eugene Applebaum College of Pharmacy and Health Sciences

  Co-Author: jason M. Pogue, PharmD – University of Michigan, College of Pharmacy

  Co-Author: Lilian M. Abbo, MD, MBA (she/her/hers) – University of Miami Miller School of Medicine, Jackson Health System

  Co-Author: Renee Ackley, PharmD, BCPS, BCIDP – Atrium Health

  Co-Author: Samuel L. Aitken, PharmD, MPH – Michigan Medicine

  Co-Author: Benjamin Albrecht, PharmD, BCIDP (he/him/his) – Emory University Hospital

  Co-Author: Ahmed Babiker, MBBS – Emory University

  Co-Author: Rachel Burgoon, Pharm.D. – Medical University of South Carolina

  Co-Author: Kimberly C. Claeys, PharmD, PhD (she/her/hers) – University of Maryland Baltimore

  Co-Author: Brooke Curry, PharmD – University of Illinois at Chicago

  Co-Author: Kate DeSear, PharmD, BCIDP, AAHIVP, FIDSA (she/her/hers) – UF Health Shands Hospital

  Co-Author: Jason C. Gallagher, PharmD – Temple University

  Co-Author: Esther Golnabi, PharmD – UT Southwestern

  Co-Author: Sarah B. Green, PharmD, BCIDP, AAHIVP – Emory University Hospital

  Co-Author: Alan E. Gross, PharmD – University of Illinois

  Co-Author: Emily L. Heil, PharmD, MS – University of Maryland School of Pharmacy

  Co-Author: Krutika M. Hornback, PharmD, BCIDP (she/her/hers) – MUSC Health

  Co-Author: Keith S. Kaye, MD, MPH – Rutgers Robert Wood Johnson Medical School

  Co-Author: Trieu-Vi Khuu, NA – University of North Carolina

  Co-Author: Megan Klatt, PharmD, BCIDP (she/her/hers) – The University of Kansas Health System

  Co-Author: Ellen G. Kline, MS – University of Pittsburgh

  Co-Author: Ryan C. Kubat, DO – University of Kansas

  Co-Author: Wesley D. Kufel, Pharm.D., BCPS, BCIDP – Binghamton University School of Pharmacy Sciences

  Co-Author: Jae Hyoung Lee, MD – Johns Hopkins

  Co-Author: Alexander Lepak, MD, FIDSA – University of Wisconsin School of Medicine and Public Health

  Co-Author: Conan MacDougall, PharmD, MAS (he/him/his) – University of California San Francisco

  Co-Author: Anjali Majumdar, MD – Rutgers-Robert Wood Johnson Medical School

  Co-Author: Amy Mathers, MD, D(ABMM) (she/her/hers) – University of Virginia

  Co-Author: Erin K. McCreary, PharmD (she/her/hers) – University of Pittsburgh Medical Center

  Co-Author: William R. Miller, M.D. – Houston Methodist Research Institute

  Co-Author: Marguerite Monogue, PharmD – University of Texas Southwestern Medical Center

  Co-Author: W. Justin Moore, PharmD, MS, BCPS, BCIDP (he/him/his) – Northwestern Medicine

  Co-Author: Shannon Olson, BS Pharm,BCIDP – Sinai-Grace Hospital Detroit Medical Center

  Co-Author: Jessica Oxer, n/a – Weill Cornell Medicine

  Co-Author: Jeffrey C. Pearson, PharmD (he/him/his) – Brigham and Women's Hospital

  Co-Author: Christine Pham, PharmD, BCIDP – University of California, Los Angeles; David School of Medicine/University of California, Los Angeles

  Co-Author: Paulette Pinargote, MD – Lousiana State University Health Shreveport

  Co-Author: Christopher Polk, MD – Atrium Health

  Co-Author: Michael J. Satlin, MD – Weill Cornell Medicine

  Co-Author: Sarah W. Satola, PhD – Emory University School of Medicine, Division of Infectious Diseases

  Co-Author: Sunish Shah, PharmD – Antibiotic Management Program, UPMC Presbyterian Hospital, Pittsburgh, PA

  Co-Author: Pranita Tamma, MD, MHS – Johns Hopkins School of Medicine

  Co-Author: Truc Cecilia Tran, PharmD – Houston Methodist Research Institute

  Co-Author: David van Duin, MD, PhD – University of North Carolina at Chapel Hill

  Co-Author: Mollie VanNatta, PharmD, BCPS,BCIDP – Ochsner LSU Health Shreveport

  Co-Author: Ana Vega, PharmD – Jackson Memorial Hospital

  Co-Author: Venugopalan Veena, PharmD – University of Florida, College of Pharmacy

  Co-Author: Walaiporn Wangchinda, MD – University of Michigan College of Pharmacy

  Co-Author: Lucy S. Witt, MD, MPH – Emory University

  Co-Author: Ryan K. Shields, PharmD, MS – University of Pittsburgh
• 11:06 AM – 11:18 AM US PT

  Genomic Features Associated with Non-susceptibility to Cefiderocol in Pseudomonas aeruginosa and Cross-resistance to Novel β-lactam/β-lactamase Inhibitors in the Prospective Observational Pseudomonas (POP) study
  

  Presenting Author: Stephanie L. Egge, MD – Oregon Health & Science University

  Co-Author: Phillip C. Thornton, BS – Houston Methodist Research Institute

  Co-Author: Erika Flores, PhD – Houston Methodist Research Institute

  Co-Author: Rodrigo de Paula Baptista, PhD – Houston Methodist Hospital

  Co-Author: Karim Clarke, N/A – Southwestern University

  Co-Author: Cesar A. Arias, MD, MSc, PhD (he/him/his) – Houston Methodist and Weill Cornell Medical College

  Co-Author: Vincent Tam, Pharm. D. – University of Houston

  Co-Author: Michael J. Satlin, MD – Weill Cornell Medicine

  Co-Author: William R. Miller, M.D. – Houston Methodist Research Institute
• 11:18 AM – 11:30 AM US PT

  Ceftazidime-Avibactam Versus Meropenem-Vaborbactam for the Treatment of Carbapenem-Resistant Enterobacterales Infections
  

  Presenting Author: Sara M. Karaba, MD, PhD, MHS – Johns Hopkins University

  Co-Author: Dariusz A. Hareza, MD (he/him/his) – Johns Hopkins University

  Co-Author: Armani Hawes, MD – Johns Hopkins Hospital

  Co-Author: Yehudit Bergman, MS – Johns Hopkins

  Co-Author: Suiyini Fiawoo, MD/MHS – Johns Hopkins School of Medicine

  Co-Author: Jae Hyoung Lee, MD – Johns Hopkins

  Co-Author: Sara E. Cosgrove, MD, MS – Johns Hopkins School of Medicine

  Co-Author: Patricia J. Simner, PhD – Johns Hopkins School of Medicine

  Co-Author: Pranita Tamma, MD, MHS – Johns Hopkins School of Medicine
• 11:30 AM – 11:43 AM US PT

  Modeling Strain-Dependent Variability in Carbapenem-Resistant Klebsiella pneumoniae Colonization in the Malnourished Host
  

  Presenting Author: Thomas Holowka, MD, PhD – University of North Carolina, Chapel Hill

  Co-Author: Jamie Xiao (she/her/hers) – University of North Carolina

  Co-Author: Kalisvar Marimuthu, MBBS, MSc – National Centre for Infectious Diseases

  Co-Author: Oon Tek Ng, MBBS, MRCP, M Med, Infectious Disease Specialist, MPH – National Centre for Infectious Diseases

  Co-Author: David van Duin, MD, PhD – University of North Carolina at Chapel Hill

  Co-Author: Luther A. Bartelt, MD – University of North Carolina School of Medicine